Read While You Wait - Get immediate ebook access, if available*, when you order a print book

Chemotherapy for Leukemia

Novel Drugs and Treatment

Editors: Ueda, Takanori (Ed.)

Free Preview
  • Elucidates the latest progress in chemotherapy for leukemia and related diseases
  • Presents prospective results of basic and preclinical studies for leukemia
  • Maximizes reader insight into modern treatment methodology for leukemia
see more benefits

Buy this book

eBook $129.00
price for USA in USD
  • ISBN 978-981-10-3332-2
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $169.99
price for USA in USD
  • Customers within the U.S. and Canada please contact Customer Service at +1-800-777-4643, Latin America please contact us at +1-212-460-1500 (24 hours a day, 7 days a week). Pre-ordered printed titles are excluded from promotions.
  • Due: May 17, 2017
  • ISBN 978-981-10-3330-8
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
Softcover $169.99
price for USA in USD
  • ISBN 978-981-10-9844-4
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
  • Usually dispatched within 3 to 5 business days.
About this book

This book focuses on the latest progress in chemotherapy for leukemia and related diseases, including still-ongoing but promising studies. The effectiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has been made possible with the development of molecular targeted agents such as bcr-abl tyrosine kinase inhibitors and all-trans retinoic acid. The antibody for the unique target of chemokine receptor 4 for adult T-cell leukemia/lymphoma, or FLT3 inhibitors (signaling inhibitors) has been applied to other leukemias. Also, chemotherapeutic agents including antimetabolite analogues such as clofarabine, and azacitidine (an epigenetic regulator) have undergone progressive development. Meanwhile, the novel concept of therapy targeting leukemic stem cells has been developed. The contributors discuss prospective results of basic and preclinical studies and clinical possibilities based on the effects for leukemic stem cells.

This work facilitates a comprehensive understanding of modern treatment methodology for leukemia. The volume therefore will greatly benefit not only hematologists but also oncologists, all physicians who specialize in blood cancer, and pharmacologists who are involved in the development of therapeutic agents for leukemia.

About the authors

Takanori Ueda

Vice-President, University of Fukui Faculty of Medical Sciences,

3-9-1 Bunkyo, Fukui 910-8507, Japan

Table of contents (20 chapters)

Table of contents (20 chapters)

Buy this book

eBook $129.00
price for USA in USD
  • ISBN 978-981-10-3332-2
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $169.99
price for USA in USD
  • Customers within the U.S. and Canada please contact Customer Service at +1-800-777-4643, Latin America please contact us at +1-212-460-1500 (24 hours a day, 7 days a week). Pre-ordered printed titles are excluded from promotions.
  • Due: May 17, 2017
  • ISBN 978-981-10-3330-8
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
Softcover $169.99
price for USA in USD
  • ISBN 978-981-10-9844-4
  • Free shipping for individuals worldwide
  • Immediate ebook access, if available*, with your print order
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Chemotherapy for Leukemia
Book Subtitle
Novel Drugs and Treatment
Editors
  • Takanori Ueda
Copyright
2017
Publisher
Springer Singapore
Copyright Holder
Springer Nature Singapore Pte Ltd.
eBook ISBN
978-981-10-3332-2
DOI
10.1007/978-981-10-3332-2
Hardcover ISBN
978-981-10-3330-8
Softcover ISBN
978-981-10-9844-4
Edition Number
1
Number of Pages
VIII, 361
Number of Illustrations
31 b/w illustrations, 51 illustrations in colour
Topics

*immediately available upon purchase as print book shipments may be delayed due to the COVID-19 crisis. ebook access is temporary and does not include ownership of the ebook. Only valid for books with an ebook version. Springer Reference Works and instructor copies are not included.